The platform includes:
§ LVivo EF - Auto Ejection Fraction analysis, a key indicator of cardiac function, essential in cases of heart failure, shock, chest pain, as well as cardiac and surgical procedures.
§ LVivo Strain - Auto evaluation of segmental and global Left Ventricle (LV) strain, an early indicator for reduced LV function that is especially important in patients undergoing chemotherapy. Strain analysis is now a reimbursable exam in the US.
§ LVivo SWM - Auto evaluation of the Segmental Wall Motion of the 17 muscle segments of the left ventricle. LVivo SWM provides information about the contraction of each of the segments and the global contractility. Identifying wall motion abnormalities is especially important during and after coronary events.
Konica Minolta and DiA will demonstrate LVivo Toolbox during the upcoming Radiological Society of North America (RSNA) 2020 virtual meeting.
About Konica Minolta Healthcare Americas, Inc.
Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. With over 75 years of endless innovation, Konica Minolta is globally recognized as a leader providing cutting-edge technologies and comprehensive support aimed at providing real solutions to meet customers' needs and helping make better decisions sooner. Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, NJ, is a unit of Konica Minolta, Inc. (TSE:4902).
About DiA Imaging Analysis
DiA Imaging Analysis is a leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. The company's LVivo product line for cardiac and abdominal auto analysis allows clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency and accuracy. DiA serves thousands of end-users worldwide.
Back to HCB News
